<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <Volume-Issue>Volume 1; Issue 3</Volume-Issue>
      <Season>(May-Jun, 2020)</Season>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>A Case Report of Severe Minocycline-Induced DRESS Affecting Multiple Organs</ArticleTitle>
          <FirstName>Bartlomiej Witczak</FirstName>
      <Abstract>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) may affect multiple organs, and may be fatal. This case illustrates the seriousness of the syndrome and that several different organs systems may be involved. In the reported patient, the following organs were involved during the illness: skin, kidneys, lungs and lymph glands. However, CNS, red blood cells, thrombocytes and electrolytes may also have been directly or indirectly involved in the syndrome. The patient was very ill and his kidney function never recovered.</Abstract>
      <Keywords>Allergy,Eosinophil erythrocytes,DRESS,Kidney failure</Keywords>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=7339&amp;title=A Case Report of Severe Minocycline-Induced DRESS Affecting Multiple Organs</Abstract>
        <References>Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC. The DRESS syndrome: a literature review. The American journal of medicine 2011; 124: 588-597.&#13;
Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. Journal of the American Academy of Dermatology 2013a; 68: 693.e1-14; quiz 706-8.&#13;
Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. Journal of the American Academy of Dermatology 2013b; 68: 709.e1-9; quiz 18-20.&#13;
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? The British journal of dermatology 2007; 156: 609-611.&#13;
Morito H, Ogawa K, Fukumoto T, Kobayashi N, Morii T, Kasai T, Nonomura A, Kishimoto T, Asada H. Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms. Clinical and experimental dermatology 2014; 39: 284-291.&#13;
Muller P, Dubreil P, Mahe A, Lamaury I, Salzer B, Deloumeaux J, Strobel M. Drug Hypersensitivity Syndrome in a West-Indian population. European journal of dermatology: EJD 2003; 13: 478-481.&#13;
Picard D, Janela B, Descamps V, Dand;#39;Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Science translational medicine 2010; 2: 46ra62.</References>